Granahan Investment Management, LLC Sangamo Therapeutics, Inc Transaction History

Granahan Investment Management, LLC

$2.12 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $2.54 Million - $3.82 Million	-348,473 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $1.06 Million - $1.41 Million	117,129 Added 50.63%	348,473 $3.14 Million
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $130,948 - $162,752	12,876 Added 5.89%	231,344 $2.77 Million
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $429,847 - $673,611	-39,508 Reduced 15.31%	218,468 $2.74 Million
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $1.33 Million - $2.63 Million	144,588 Added 127.52%	257,976 $4.03 Million
Q3 2020 Nov 12, 2020	SELL	$9.38 - $12.48 $99,080 - $131,826	-10,563 Reduced 8.52%	113,388 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $141,917 - $270,350	22,853 Added 22.6%	123,951 $1.11 Million
Q1 2020 May 12, 2020	SELL	$5.05 - $8.85 $7,761 - $13,602	-1,537 Reduced 1.5%	101,098 $644,000
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $8,158 - $11,887	1,016 Added 1.0%	102,635 $859,000
Q3 2019 Nov 15, 2019	BUY	$9.05 - $12.22 $66,698 - $90,061	7,370 Added 7.82%	101,619 $920,000
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $23,205 - $34,555	-2,652 Reduced 2.74%	94,249 $1.02 Million
Q1 2019 May 14, 2019	SELL	$7.72 - $12.81 $54,935 - $91,155	-7,116 Reduced 6.84%	96,901 $924,000
Q4 2018 Feb 13, 2019	SELL	$9.51 - $16.6 $373,267 - $651,550	-39,250 Reduced 27.4%	104,017 $1.19 Million
Q3 2018 Nov 13, 2018	BUY	$13.05 - $19.05 $25,042 - $36,556	1,919 Added 1.36%	143,267 $2.43 Million
Q2 2018 Aug 15, 2018	BUY	$13.9 - $19.8 $166,702 - $237,461	11,993 Added 9.27%	141,348 $2.01 Million
Q1 2018 May 14, 2018	SELL	$16.7 - $26.35 $440,028 - $694,296	-26,349 Reduced 16.92%	129,355 $2.46 Million
Q4 2017 Feb 12, 2018	SELL	$11.6 - $17.35 $3.59 Million - $5.37 Million	-309,386 Reduced 66.52%	155,704 $2.55 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $3.91 Million - $6.98 Million	465,090	465,090 $6.98 Million

Others Institutions Holding SGMO

# of Institutions

118

Shares Held

43.8M

Call Options Held

576K

Put Options Held

1.17M

Vanguard Group Inc Valley Forge, PA

9.37M
Shares

$11 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

9.23M
Shares

$10.8 Million
0.05% of portfolio
State Street Corp Boston, MA

5.02M
Shares

$5.87 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.08M
Shares

$3.61 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account